US4800211A - 5-methylthio-3-hydroxybenzo [b]thiophene-2-carboxamide derivatives as cyclooxygenase and lipoxygenase inhibitors - Google Patents

5-methylthio-3-hydroxybenzo [b]thiophene-2-carboxamide derivatives as cyclooxygenase and lipoxygenase inhibitors Download PDF

Info

Publication number
US4800211A
US4800211A US06/897,576 US89757686A US4800211A US 4800211 A US4800211 A US 4800211A US 89757686 A US89757686 A US 89757686A US 4800211 A US4800211 A US 4800211A
Authority
US
United States
Prior art keywords
ch
example
thiophene
treating
cyclooxygenase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US06/897,576
Inventor
Allan N. Tischler
Philippe L. Durette
Bruce E. Witzel
Thomas J. Lanza, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to US06/897,576 priority Critical patent/US4800211A/en
Assigned to MERCK & CO., INC. reassignment MERCK & CO., INC. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: LANZA, THOMAS J., JR., DURETTE, PHILIPPE L., TISCHLER, ALLAN N., WITZEL, BRUCE E.
Application granted granted Critical
Publication of US4800211A publication Critical patent/US4800211A/en
Anticipated expiration legal-status Critical
Application status is Expired - Fee Related legal-status Critical

Links